Login to Your Account

Intercell Gets Stock Boost as FDA Approves Ixiaro

By Cormac Sheridan

Wednesday, April 1, 2009
Shares in Intercell AG received a significant boost Tuesday on news that the FDA approved its Japanese Encephalitis Virus (JEV) vaccine Ixiaro late Monday. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription